Conceivable Life Sciences Series A

Conceivable Life Sciences raised a $50M Series A in September 2025 from ACME Capital, Advance Venture Partners, Artis Ventures and Stride.VC.

$50,000,000 Amount

Investors

  • ACME Capital

    ACME Capital is an early-stage venture capital firm that invests in deep tech companies. The page displays a portfolio of investments including Plot AI, Harmattan AI, Canopy, and Stendr, along with testimonials from founders describing the firm's involvement in their companies.

  • Artis Ventures

    ARTIS is guided by a singular belief: that the future of the human condition can be made more resilient through the bold application of frontier technologies. Our mission is to support visionary founders who are reimagining the systems that sustain life itself — from the cellular to the societal. By catalyzing breakthroughs in areas like AI, we aim to build toward a world where health is proactive, personalized, and resilient — empowering humanity not just to survive, but to flourish.

  • Stride.VC

    Stride.VC is a venture capital firm that invests in startups at early stages, as evidenced by their portfolio companies listed (Zoopla, Deliveroo, Strapi, etc.) and their statement about writing 'meaningful cheques at the stage it really matters.' They are authorized and regulated by the Financial C

  • AVAdvance Venture Partners

Something wrong or missing? Send an update. Fixed within 24 hours.